Strata Critical Medical Inc Warrants
SRTAW
SRTAW was delisted on the 6th of May, 2026.
12 hedge funds and large institutions have $6.32M invested in Strata Critical Medical Inc Warrants in 2022 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 3 increasing their positions, 4 reducing their positions, and 0 closing their positions.
8.9% more ownership
Funds ownership: 0% → 8.9% (+8.9%)
1% more capital invested
Capital invested by funds: $6.25M → $6.32M (+$65K)
0% more funds holding
Funds holding: 12 → 12 (0)
25% less repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 4
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
LP
LMR Partners
London,
United Kingdom
|
+$95.8K |
| 2 |
Walleye Capital
New York
|
+$91K |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$543 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PFM
Privium Fund Management
Amsterdam,
Netherlands
|
-$33.6K |
| 2 |
ICM
Ionic Capital Management
New York
|
-$21.8K |
| 3 |
HF
HRT Financial
New York
|
-$7.43K |
| 4 |
SM
Skaana Management
Brooklyn,
New York
|
-$6.36K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
LP
1
LMR Partners
London,
United Kingdom
| $2.67M | +$95.8K | +113,048 | +21% |
|
2
Goldman Sachs
New York
| $1.47M | – | – | – |
|
|
3
Walleye Capital
New York
| $980K | +$91K | +107,422 | +8% |
|
|
ICM
4
Ionic Capital Management
New York
| $488K | -$21.8K | -25,717 | -3% |
|
5
Morgan Stanley
New York
| $448K | – | – | – |
|
|
DCM
6
Difesa Capital Management
New York
| $141K | – | – | – |
|
|
SM
7
Skaana Management
Brooklyn,
New York
| $62K | -$6.36K | -7,500 | -7% |
|
|
HF
8
HRT Financial
New York
| $27K | -$7.43K | -8,770 | -17% |
|
|
CL
9
CSS LLC
Chicago,
Illinois
| $13K | – | – | – |
|
|
PFM
10
Privium Fund Management
Amsterdam,
Netherlands
| $7K | -$33.6K | -39,702 | -77% |
|
|
11
UBS Group
Zurich,
Switzerland
| $4K | +$543 | +641 | +10% |
|
SRTAW Hedge Fund Activity: Q3 2022 in Review
12 of the 5,806 institutional investors tracked by Wall St. Rank reported a position in Strata Critical Medical Inc Warrants (SRTAW) for Q3 2022, worth a combined $6.32M — up 1% from $6.25M a quarter earlier.
Fund positioning in SRTAW was balanced in Q3 2022: 0 funds opened new positions, 0 closed out, 3 added to existing stakes and 4 trimmed.
The largest buyer was LMR Partners, adding an estimated $95.8K. The largest seller was Privium Fund Management, cutting an estimated $33.6K.
- 12 institutional investors held Strata Critical Medical Inc Warrants (SRTAW) as of Q3 2022, unchanged from Q2 2022.
- Funds reported $6.32M of Strata Critical Medical Inc Warrants stock for Q3 2022, up 1% quarter-over-quarter.
- 0 funds opened new Strata Critical Medical Inc Warrants positions in Q3 2022 and 0 closed out.
- The largest Strata Critical Medical Inc Warrants buyer in Q3 2022 was LMR Partners, an estimated $95.8K added.
- The largest Strata Critical Medical Inc Warrants seller in Q3 2022 was Privium Fund Management, an estimated $33.6K sold.
Based on aggregated 13F filings for Q3 2022.